Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A

Duiyue Xu(China Pharmaceutical University), Changlin Zhou(Lanzhou University Second Hospital)
International Journal of Oncology
September 8, 2020
Cited by 57


Related Papers